Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -33.71%82.2M | ---- | -20.48%124M | ---- | 264.13%155.94M | 10.01%51.24M | 293.35%42.82M | 455.72%46.58M | 116.49%10.89M | 27.01%-13.09M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 63.29%-4.38M | ---- | 95.64%-11.94M | ---- | -13.85%-273.71M | -14.86%-136.97M | -49.02%-240.42M | -66.51%-119.25M | -53.85%-161.33M | -44.50%-71.62M |
| Dividend (income)- adjustment | -6.15%-656K | ---- | 12.96%-618K | ---- | -22.41%-710K | ---726K | 39.52%-580K | ---- | ---959K | ---- |
| Attributable subsidiary (profit) loss | 26.22%-29.76M | ---- | 21.53%-40.34M | ---- | -987.37%-51.4M | -225.35%-27.26M | 81.36%-4.73M | 73.48%-8.38M | 62.65%-25.36M | -11.15%-31.59M |
| Impairment and provisions: | 271.02%65.01M | ---- | -78.89%17.52M | ---- | 116.86%83M | -11.08%7.89M | 212.67%38.27M | 75.15%8.87M | -77.42%12.24M | -75.97%5.07M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | --31.16M | ---- | ---- | ---- | 18.90%1.9M | ---- |
| -Impairment of trade receivables (reversal) | 360.41%4.51M | ---- | -55.97%980K | ---- | 706.52%2.23M | -11.08%7.89M | -44.69%276K | 75.15%8.87M | --499K | 454.27%5.07M |
| -Other impairments and provisions | 265.73%60.5M | ---- | -66.66%16.54M | ---- | 30.58%49.62M | ---- | 286.08%38M | ---- | -81.29%9.84M | ---- |
| Revaluation surplus: | --18.12M | ---- | ---- | ---- | -214.02%-123.08M | ---- | -10,107.29%-39.2M | ---41.84M | 98.09%-384K | ---- |
| -Fair value of investment properties (increase) | --5.92M | ---- | ---- | ---- | -29,525.04%-209.21M | ---- | 104.26%711K | ---- | -33,938.78%-16.68M | ---- |
| -Other fair value changes | --12.2M | ---- | ---- | ---- | 315.83%86.13M | ---- | -344.90%-39.91M | ---41.84M | 181.09%16.3M | ---- |
| Asset sale loss (gain): | 101.48%744K | ---- | -3,041.13%-50.41M | ---- | 308.01%1.71M | -86.32%96K | -109.16%-824K | -92.01%702K | -76.06%9M | --8.79M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---49.03M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 153.80%744K | ---- | -180.69%-1.38M | ---- | -44.67%1.71M | -86.34%96K | -65.57%3.1M | -92.00%703K | 27,169.70%9M | --8.79M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---3.92M | ---1K | ---- | ---- |
| Depreciation and amortization: | 25.71%58.59M | ---- | -39.00%46.61M | ---- | -1.10%76.4M | -3.51%38.19M | 9.62%77.25M | 18.74%39.58M | 33.27%70.47M | 39.32%33.33M |
| -Amortization of intangible assets | 17.40%877K | ---- | 67.11%747K | ---- | --447K | --65K | ---- | ---- | ---- | ---- |
| Financial expense | -20.50%71.9M | ---- | -35.12%90.43M | ---- | 6.03%139.38M | 9.67%69.09M | 22.77%131.45M | 24.43%62.99M | -13.48%107.07M | -8.44%50.62M |
| Exchange Loss (gain) | 16.69%-2.04M | ---- | -261.85%-2.44M | ---- | -76.01%1.51M | -56.76%3.09M | 1,718.25%6.3M | 1,419.00%7.15M | 97.75%-389K | -626.21%-542K |
| Special items | -11.91%46.27M | ---- | 36.89%52.52M | ---- | -7.80%38.37M | -17.09%20.05M | 154.03%41.62M | 97.35%24.18M | -58.96%16.38M | 17.73%12.25M |
| Operating profit before the change of operating capital | 35.80%306M | ---- | 375.37%225.33M | ---- | -8.76%47.4M | 19.88%24.68M | 38.11%51.95M | 403.90%20.59M | 17.25%37.62M | -145.50%-6.78M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -654.34%-8.34M | ---- | -182.17%-1.11M | ---- | 265.76%1.35M | 283.33%2.23M | 108.39%368K | 158.26%582K | -345.83%-4.39M | -49,850.00%-999K |
| Accounts receivable (increase)decrease | -59.70%-932.19M | ---- | 29.44%-583.7M | ---- | 16.59%-827.28M | -12.88%-488.18M | 29.56%-991.8M | 27.54%-432.49M | -218.99%-1.41B | -64.35%-596.9M |
| Accounts payable increase (decrease) | 66.41%15.58M | ---- | -51.53%9.37M | ---- | 37.32%19.32M | -746.55%-15.38M | -78.10%14.07M | -66.99%2.38M | 54.48%64.27M | 907.55%7.2M |
| Advance payment increase (decrease) | -212.72%-9.82M | ---- | -76.76%8.71M | ---- | 7.47%37.47M | 2,945.29%27.77M | -32.47%34.87M | -103.65%-976K | 115.70%51.64M | 111.82%26.7M |
| Special items for working capital changes | 67.03%-91K | ---- | 99.21%-276K | ---- | -253.65%-34.91M | -144.33%-23.35M | -82.08%22.72M | -46.45%52.67M | 66.63%126.82M | 37.19%98.36M |
| Cash from business operations | -84.05%-628.86M | ---- | 54.84%-341.67M | ---- | 12.81%-756.65M | -32.18%-472.22M | 23.34%-867.81M | 24.38%-357.25M | -325.78%-1.13B | -79.43%-472.41M |
| China income tax paid | -6.44%-62.56M | ---- | -26.19%-58.78M | ---- | -4.17%-46.58M | ---- | -25.86%-44.71M | ---- | ---35.53M | ---- |
| Other taxs | ---- | ---- | ---- | ---- | ---- | -0.24%-29.11M | ---- | 8.66%-29.04M | ---- | -35.22%-31.79M |
| Interest received - operating | ---- | ---- | ---- | ---- | 5.18%249.17M | 13.32%127.71M | 48.20%236.9M | 70.70%112.7M | 88.55%159.85M | 85.74%66.02M |
| Special items of business | ---- | -8.95%-183.26M | ---- | ---168.2M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | -72.66%-691.42M | -8.95%-183.26M | 27.72%-400.45M | 54.98%-168.2M | 17.99%-554.06M | -36.56%-373.62M | 32.95%-675.62M | 37.56%-273.59M | -354.97%-1.01B | -74.40%-438.18M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -63.14%4.38M | ---- | 52.05%11.89M | ---- | -28.67%7.82M | 18.89%5.33M | 41.75%10.97M | 21.55%4.48M | -47.06%7.74M | -34.00%3.69M |
| Dividend received - investment | 6.15%656K | ---- | -98.28%618K | ---- | 6,108.45%36.01M | -98.23%726K | -96.65%580K | 140.24%40.92M | --17.34M | --17.03M |
| Decrease in deposits (increase) | -84.99%28.88M | ---- | 439.18%192.47M | ---- | -130.71%-56.75M | -137.30%-103.19M | 157.05%184.81M | 5,148.53%276.65M | -610.82%-323.95M | -93.00%5.27M |
| Sale of fixed assets | -99.66%10K | ---- | 4,915.25%2.96M | ---- | -91.07%59K | 340.00%44K | 844.29%661K | -64.29%10K | 288.89%70K | --28K |
| Purchase of fixed assets | 76.59%-30.99M | ---- | 43.65%-132.39M | ---- | 15.39%-234.93M | 18.80%-97.13M | 53.84%-277.68M | 61.39%-119.61M | -33.76%-601.53M | -141.52%-309.81M |
| Purchase of intangible assets | ---1.12M | ---- | ---- | ---- | ---62.4M | ---63.82M | ---- | ---- | ---- | ---- |
| Sale of subsidiaries | ---- | ---- | --564.59M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | -957.70%-4.4M | -1,561.79%-4.4M | --513K | --301K | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | --8.69M | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---12.55M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | -98.04%9.78M | ---- | --498.55M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -99.71%1.82M | -98.04%9.78M | 299.50%627.6M | 289.97%498.55M | -340.27%-314.59M | -229.44%-262.43M | 92.06%-71.45M | 171.44%202.74M | -468.90%-900.34M | -2,812.10%-283.79M |
| Net cash before financing | -403.59%-689.6M | -152.51%-173.48M | 126.15%227.15M | 151.94%330.35M | -16.27%-868.65M | -797.82%-636.06M | 60.84%-747.08M | 90.19%-70.84M | -402.45%-1.91B | -199.84%-721.97M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 0.07%4.84B | ---- | 39.80%4.84B | ---- | -2.01%3.46B | 8.38%2.59B | 48.39%3.53B | 147.81%2.39B | 116.81%2.38B | 187.78%964.44M |
| Refund | 14.54%-4.09B | ---- | -76.23%-4.78B | ---- | -13.94%-2.71B | 1.95%-1.56B | -202.07%-2.38B | -441.09%-1.59B | 3.67%-788.83M | -5.04%-293.25M |
| Interest paid - financing | -34.43%-63.31M | ---- | 28.41%-47.1M | ---- | -23.28%-65.79M | -84.21%-34.63M | -51.35%-53.36M | -15.32%-18.8M | 36.27%-35.26M | 35.29%-16.3M |
| Dividends paid - financing | -87.28%-110.84M | ---- | -38.45%-59.19M | ---- | -48.36%-42.75M | 25.55%-37.7M | -21.83%-28.81M | -115.15%-50.64M | -101.85%-23.65M | -104.50%-23.54M |
| Absorb investment income | ---- | ---- | ---- | ---- | -99.06%1.09M | -99.09%1.09M | -12.35%115.4M | --119.46M | --131.67M | ---- |
| Other items of the financing business | 3,163.79%111.95M | -51.98%36.32M | 30.61%-3.65M | 4,012.88%75.64M | -57.19%-5.27M | -66.93%-1.93M | -4.62%-3.35M | ---1.16M | 74.72%-3.2M | ---- |
| Net cash from financing operations | 910.57%690.68M | -51.98%36.32M | -114.28%-85.21M | -91.81%75.64M | -47.70%596.86M | 13.68%923.91M | -29.23%1.14B | 39.37%812.73M | 925.51%1.61B | 2,751.05%583.15M |
| Effect of rate | -33.91%-28.4M | 212.89%19.78M | -4.71%-21.21M | 83.76%-17.53M | 66.97%-20.25M | -123.03%-107.94M | -355.41%-61.31M | -705.35%-48.4M | -50.28%24.01M | 161.23%8M |
| Net Cash | -99.24%1.08M | -133.78%-137.15M | 152.22%141.94M | 41.04%405.99M | -168.97%-271.79M | -61.20%287.85M | 233.39%394.08M | 634.43%741.89M | -32.78%-295.43M | 47.17%-138.82M |
| Begining period cash | 21.27%688.29M | 21.27%688.29M | -33.97%567.56M | -43.20%567.56M | 63.16%859.6M | 89.67%999.25M | -34.00%526.84M | -34.00%526.84M | -17.91%798.26M | -17.91%798.26M |
| Cash at the end | -3.97%660.97M | -40.28%570.92M | 21.27%688.29M | -18.92%956.02M | -33.97%567.56M | -3.37%1.18B | 63.16%859.6M | 82.84%1.22B | -34.00%526.84M | -4.19%667.44M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | Hengjian Accounting Firm Limited | -- | Hengjian Accounting Firm Limited | -- | Hengjian Accounting Firm Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.